Eutherapeutic Pharmaceutical Ibandronate Sodium for Cancer Ibandronate Sodium

Details:

Detailed Product Description

Eutherapeutic Pharmaceutical Ibandronate Sodium CAS 138844-81-2 for Cancer


Quick Detail:

Ibandronate sodium
Synonym: Sodium [1-hydroxy-1-(hydroxy-oxido-phosphoryl)-3-(methyl-pentyl-amino) propyl]phosphonic acid; (1-Hydroxy-3-(methylpentylamino)propylidene)bisphosphonic acid monosodium salt; Ibandronate Sodium Anhydrous; Bondronat, (1-Hydroxy-3-(methylpentylamino)propylidene)bisphosphonic acid sodium; Ibandronate sodium; Bondronat; Ibandronate sodiuM Bondronat
InChI: InChI=1/C9H23NO7P2. Na/c1-3-4-5-7-10(2)8-6-9(11, 18(12, 13)14)19(15, 16)17; /h11H, 3-8H2, 1-2H3, (H2, 12, 13, 14)(H2, 15, 16, 17); /q; +1/p-1
Purity: 99%
CAS No.: 138844-81-2
Grade: Pharmaceutical Grade
Place of Origin: Wuhan, China
Lead time: 1-2 days upon receipt of payment
Delivery time: Usually 4-6 working days by air
Storage: Store in a cool, dry place. Do not store in direct sunlight. Store in a tightlyclosed container; Storage temp: 2-8° C
Usage: Ibandronate sodium is a potent bisphosphonate drug used in the prevention and treatment of osteoporosis and metastasis-associated skeletal fractures in peoplewith cancer. It may also be used to treat hypercalcemia (elevated blood calcium levels).


Product description:

MF: C9H22NNaO7P2
MW: 341.21
Assay ≥ 99.0%
Boiling Point: 587.8 ° C at 760 mmHg
Vapour: 2.88E-16mmHg at 25° C
Flash Point: 309.3 ° C
Storage temp: 2-8° C
Appearance: White crystalline powder


Specifications

Product name: Ibandronate sodium
Appearance: White crystalline powder
Assay: 99%min
Molecular formula: C9H22NNaO7P2
Molecular weight: 341.21